SEC CIK 1112072
FARAH ROGER N
Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CVSview stock → | 19,438.453 | 2025-11-30 |
| PGRview stock → | 2,011 | 2026-05-08 |
| RLview stock → | 0 | 2014-05-27 |
Position History — CVS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CVS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-11-30 | Tax withholding | 9,748 | $80.36 | 19,438.453 |
| 2024-11-30 | Grant / award | 50,125 | $59.85 | 50,125 |
| 2024-05-16 | Grant / award (derivative) | 5,302.5 | $57.52 | 35,561.33 |
| 2023-11-15 | Grant / award (derivative) | 4,411.98 | $69.13 | 29,639.02 |
| 2023-05-18 | Grant / award (derivative) | 3,917.18 | $69.31 | 24,634.36 |
| 2022-11-17 | Grant / award (derivative) | 3,212.89 | $94.93 | 20,574.9 |
| 2022-05-11 | Grant / award (derivative) | 3,112.56 | $97.99 | 17,083.73 |
| 2021-11-17 | Grant / award (derivative) | 1,671.52 | $92.73 | 13,899.23 |
| 2021-05-13 | Grant / award (derivative) | 1,839.33 | $84.27 | 12,087.3 |
| 2020-11-18 | Grant / award (derivative) | 2,336.1 | $66.35 | 10,111.69 |
| 2020-05-14 | Grant / award (derivative) | 2,487.56 | $62.31 | 7,649.33 |
| 2019-11-20 | Grant / award (derivative) | 2,068.87 | $74.92 | 5,081.12 |
| 2019-05-16 | Grant / award (derivative) | 2,963.67 | $52.30 | 2,963.67 |
| 2018-11-28 | Grant / award | 1,308 | $80.27 | 1,308 |
| 2018-11-28 | Grant / award | 2,513 | — | 3,821 |
| 2018-11-28 | — | — | — | 3,821 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.